Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA Panel Backs Testing Of Concurrent And Sequential Mammography CAD

This article was originally published in The Gray Sheet

Executive Summary

FDA should require sponsors of computer-aided detection for mammography to test their devices with both sequential and concurrent reading approaches, FDA's Radiological Devices Advisory Panel recommends
Advertisement

Related Content

No Clinical Data Needed For Some Computer-Aided Detection Devices - Panel
No Clinical Data Needed For Some Computer-Aided Detection Devices - Panel
CAD Mammography Leads To Unnecessary Patient Recalls, Biopsies – ECRI
CAD Mammography Leads To Unnecessary Patient Recalls, Biopsies – ECRI
People In Brief
People In Brief
FDA Radiology Panel Will Consider Computer-Aided Detection Issues In March
FDA Radiology Panel Will Consider Computer-Aided Detection Issues In March
CAD With Mammograms May Hurt More Than Help, Study Shows
Advertisement
UsernamePublicRestriction

Register

MT025855

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel